Corcept Therapeutics Incorporated (LON:0I3Q)
68.40
-3.38 (-4.71%)
At close: Jul 7, 2025
Corcept Therapeutics Employees
Corcept Therapeutics had 500 employees as of December 31, 2024. The number of employees increased by 148 or 42.05% compared to the previous year.
Employees
500
Change (1Y)
148
Growth (1Y)
42.05%
Revenue / Employee
1.06M GBP
Profits / Employee
205.12K GBP
Market Cap
5.63B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Indivior | 1,051 |
Corcept Therapeutics News
- 11 days ago - Beyond Cushing's: The Undervalued Potential Of Corcept's Cortisol Modulators - Seeking Alpha
- 17 days ago - Corcept Presents Data from Treatment Phase of CATALYST Trial at American Diabetes Association's 85th Scientific Sessions with Simultaneous Publication in Diabetes Care - Benzinga
- 17 days ago - Corcept Presents Data from Treatment Phase of CATALYST Trial at American Diabetes Association's 85th Scientific Sessions with Simultaneous Publication in Diabetes Care - Business Wire
- 21 days ago - Insider Decision: Gary Charles Robb Offloads $225K Worth Of Corcept Therapeutics Stock - Benzinga
- 27 days ago - Corcept: Remains A Strong Buy On Recent Weakness And Aggressive Sales Force Hiring - Seeking Alpha
- 27 days ago - Major Update: LEONARD BAKER JR At Corcept Therapeutics Exercises Options, Realizing $0 - Benzinga
- 4 weeks ago - 20 stocks you should avoid — no matter how well the market does - Market Watch
- 5 weeks ago - Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting - Business Wire